Insufficient scRNA-seq data for expression of ASPRV1 at single-cell level.
Insufficient scRNA-seq data for expression of ASPRV1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 390.89 | 2633 / 2642 | 100% | 7.34 | 703 / 705 |
prostate | 98% | 239.09 | 239 / 245 | 96% | 2.29 | 482 / 502 |
adrenal gland | 97% | 207.01 | 250 / 258 | 93% | 3.43 | 214 / 230 |
kidney | 92% | 194.25 | 82 / 89 | 93% | 3.59 | 835 / 901 |
breast | 99% | 211.65 | 453 / 459 | 86% | 2.99 | 961 / 1118 |
uterus | 99% | 335.31 | 169 / 170 | 84% | 9.61 | 384 / 459 |
thymus | 91% | 142.40 | 591 / 653 | 75% | 2.24 | 455 / 605 |
ovary | 100% | 469.29 | 180 / 180 | 65% | 1.74 | 280 / 430 |
lung | 91% | 175.81 | 525 / 578 | 69% | 3.29 | 793 / 1155 |
skin | 80% | 24389.46 | 1440 / 1809 | 78% | 26.20 | 369 / 472 |
esophagus | 73% | 134.62 | 1060 / 1445 | 82% | 5.52 | 150 / 183 |
intestine | 81% | 141.39 | 785 / 966 | 63% | 1.34 | 331 / 527 |
bladder | 71% | 137.29 | 15 / 21 | 65% | 5.34 | 326 / 504 |
stomach | 52% | 74.14 | 185 / 359 | 65% | 1.41 | 186 / 286 |
spleen | 100% | 400.92 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.56 | 1 / 1 |
adipose | 97% | 246.37 | 1170 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 6% | 7.61 | 21 / 328 | 90% | 2.38 | 160 / 178 |
liver | 51% | 69.89 | 115 / 226 | 45% | 0.82 | 184 / 406 |
tonsil | 0% | 0 | 0 / 0 | 93% | 5.84 | 42 / 45 |
blood vessel | 90% | 163.54 | 1195 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 865.58 | 805 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 1.70 | 68 / 80 |
lymph node | 0% | 0 | 0 / 0 | 83% | 1.70 | 24 / 29 |
muscle | 80% | 151.04 | 640 / 803 | 0% | 0 | 0 / 0 |
heart | 63% | 89.66 | 539 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016485 | Biological process | protein processing |
GO_0043588 | Biological process | skin development |
GO_0016020 | Cellular component | membrane |
GO_0004190 | Molecular function | aspartic-type endopeptidase activity |
Gene name | ASPRV1 |
Protein name | Retroviral-like aspartic protease 1 (EC 3.4.23.-) (Skin-specific retroviral-like aspartic protease) (SASPase) (Skin aspartic protease) (TPA-inducible aspartic proteinase-like protein) (TAPS) |
Synonyms | SASP |
Description | FUNCTION: Protease responsible for filaggrin processing, essential for the maintenance of a proper epidermis organization. . |
Accessions | Q53RT3 ENST00000320256.6 [Q53RT3-2] |